Latest treatment of multiple sclerosis Stories
Long term clinical trials will increase likelihood of prescriptions receiving approval and adoption by physicians, finds Frost & Sullivan MOUNTAIN VIEW, Calif., May 7, 2015 /PRNewswire/ --
Interim Results Indicate Positive Efficacy Trends in FDA-Approved Phase I Clinical Stem Cell Trial For Patients with Multiple Sclerosis NEW YORK, April 23, 2015 /PRNewswire/ -- Tisch
- Data analyses in relapsing MS highlight MRI outcomes and 'no evident disease activity' (NEDA) measure for Rebif® (interferon beta-1a) vs.
TOORAK, Australia, Sept.
~Crew of Sailors with MS including Bostonian Demonstrate Ability to Overcome Personal Challenges BOSTON, Sept.
LONDON, June 26, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
MISSISSAUGA, ON, June 25, 2014 /CNW/ - Biogen Idec Canada announces today that TECFIDERA(TM) (dimethyl fumarate) is now available for reimbursement in British Columbia (B.C.) through B.C.
Current Neurologist-Reported Patient Share for Tecfidera Exceeds that of Genzyme's Aubagio and Novartis's Gilenya Combined, According to Findings from Decision Resources Group BURLINGTON, Mass.,
NESS ZIONA, Israel, May 27, 2014 /PRNewswire/ -- Mapi Pharma Ltd.
- To say in too many words; to express verbosely.
- To express in too many words: sometimes used reflexively.
- The leading idea or a repeated phrase, as of a song or ballad; the refrain; burden.